General MedicationsORALStandard
AZITHROMYCIN
AZITHROMYCIN
Standard Dose
EQ 250MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary
Approval overview AZITHROMYCIN is listed in Drugs@FDA under application 215772 (ANDA).
Review priority: UNKNOWN Marketing status: Prescription Active ingredient AZITHROMYCIN Form and strength TABLET;ORAL - EQ 250MG BASE Sponsor STRIDES PHARMA Submission history Latest submission status date: 2024-07-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview AZITHROMYCIN is listed in Drugs@FDA under application 215772 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient AZITHROMYCIN Form and strength TABLET;ORAL - EQ 250MG BASE Sponsor STRIDES PHARMA Submission history Latest submission status date: 2024-07-08 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.